---
title: Pancreatic Cancer in Dogs
description: Learn about pancreatic cancer in dogs. Read about symptoms, treatment options, and the promise of targeted therapies. Early detection can improve outcomes, so consult your veterinarian for tailored care and management strategies.
image: https://blog.fidocure.com/hubfs/Blog_PancreaticCancer.png
---

[![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/fidocure_logo.png?width=296&height=68&name=fidocure_logo.png "FidoCure")](https://www.fidocure.com/)

- [Veterinarians](https://fidocure.com/for-veterinarians/) 
    - [Portal Login](https://dvm.fidocure.com/)
    - [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet)
    - [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
    - [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars)
- [Pet Parents](https://fidocure.com/pet-parents/)
- [About Us](https://fidocure.com/about-us/)
- [How it works](https://fidocure.com/how-it-works/)
- [Find a Clinic](https://fidocure.com/find-a-clinic/)
- [Contact Us](https://fidocure.com/contact-us/)

# Pancreatic Cancer in Dogs

![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png?width=45&name=Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png) 

[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure)

[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.fidocure.com/fidocure-blog/pancreatic-cancer-in-dogs) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.fidocure.com/fidocure-blog/pancreatic-cancer-in-dogs) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.fidocure.com/fidocure-blog/pancreatic-cancer-in-dogs)

Pancreatic cancer, though rare, is a serious condition in dogs, with two of the most common forms being insulinoma and pancreatic adenocarcinoma. These tumors can be life-threatening, but early detection and specialized care, including emerging treatments like targeted therapies, offer new hope for affected dogs.

### **Common Pancreatic Tumors**

- **Insulinoma**: These tumors affect the pancreas' insulin-producing cells, leading to low blood sugar. Insulinomas are usually malignant and can spread to other organs. Symptoms include weakness, confusion, and seizures.
- **Pancreatic Adenocarcinoma:** This aggressive cancer arises from the pancreas' glandular tissue and often spreads to other organs. Symptoms like vomiting, weight loss, and abdominal pain are common, and the prognosis is typically poor due to its fast-spreading nature.

### **Treatment Options**

- **Surgery:** For insulinoma, surgery can be curative if caught early, though many cases still require further treatment. Surgery for adenocarcinoma is more challenging, and may not always be appropriate given a high rate of metastasis at diagnosis.
- **Chemotherapy:** Used when tumors have spread or surgery is not possible, agents like streptozocin and diazoxide are often discussed for insulinoma, while gemcitabine and doxorubicin may be employed for adenocarcinoma.
- **Targeted Therapies:** Palladia (toceranib phosphate), a targeted therapy for various cancers, may offer benefits in some cases. While not specifically approved for insulinoma, its ability to target certain growth receptors like VEGFR and PDGFR has made it a potential option for managing cancers with these molecular targets.

### **Molecular Targets for Canine Pancreatic Cancer**

Advances in cancer research have identified several mutations that may be targeted in pancreatic tumors:

- **mTOR in Insulinoma**: The mTOR pathway plays a role in insulinoma growth. Drugs inhibiting this pathway have shown potential.
- **EGFR, VEGFR, PDGFR in Adenocarcinoma**: These receptors are often overexpressed. Targeted therapies like Palladia (toceranib phosphate) may offer new treatment options.

While early, options like these are becoming increasingly utilized and investigated for their potential benefit.

### **Prognosis**

Prognosis varies depending on the type and stage of the tumor. Insulinomas can have a relatively favorable outcome if treated early, while pancreatic adenocarcinomas typically have a poor prognosis due to their aggressive nature. Advances in targeted therapies and personalized treatment plans, like those offered by FidoCure, offer new avenues for managing these challenging conditions.

If you suspect your dog may have a pancreatic tumor, consult a veterinarian or oncologist to explore treatment options that could improve your dog's quality of life.

## Related Articles

[![](https://blog.fidocure.com/hubfs/petonc.png)](https://blog.fidocure.com/fidocure-blog/the-future-of-pet-oncology-how-ai-driven-targeted-therapies-are-revolutionizing-cancer-treatment-for-dogs)

### [The Future of Pet Oncology: How AI-Driven Targeted Therapies are Revolutionizing Cancer Treatment for Dogs](https://blog.fidocure.com/fidocure-blog/the-future-of-pet-oncology-how-ai-driven-targeted-therapies-are-revolutionizing-cancer-treatment-for-dogs)

The global veterinary oncology market has been experiencing remarkable growth, reaching a valuation of [$259.4B](https://www.skyquestt.com/report/veterinary-oncology-market) in 2023. This surge reflects a significant shift in how...

![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png?width=45&name=Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png) 

[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure) 

[Read More](https://blog.fidocure.com/fidocure-blog/the-future-of-pet-oncology-how-ai-driven-targeted-therapies-are-revolutionizing-cancer-treatment-for-dogs)

[![](https://blog.fidocure.com/hubfs/Blog_Gastrointestinal%20Cancers.png)](https://blog.fidocure.com/fidocure-blog/what-are-gastrointestinal-cancers)

### [What are Gastrointestinal Cancers?](https://blog.fidocure.com/fidocure-blog/what-are-gastrointestinal-cancers)

Gastrointestinal (GI) tumors in dogs are relatively rare but can be serious when they occur. These tumors affect the stomach, intestines, or other parts of the digestive...

![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png?width=45&name=Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png) 

[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure) 

[Read More](https://blog.fidocure.com/fidocure-blog/what-are-gastrointestinal-cancers)

![fc_portal_logo_bw](https://blog.fidocure.com/hubfs/fc_portal_logo_bw.svg)

- [How it Works](https://fidocure.com/how-it-works/)
- [FAQ](https://fidocure.com/faq/)
- [Contact Us](https://fidocurestg.wpengine.com/contact-us/)
- [For Vets](https://fidocure.com/for-veterinarians/)
- [About Us](https://fidocure.com/about-us/)
- [Terms of Service](https://fidocure.com/terms-of-service/)
- [Blog](https://blog.fidocure.com/fidocure-blog)
- [Careers](https://fidocure.com/careers/)
- [Privacy Policy](https://fidocure.com/privacy-policy/)

- <https://www.instagram.com/fidocure/>
- <https://twitter.com/fidocure>
- <https://www.facebook.com/FidoCure/>
- <https://www.pinterest.com/fidocure/>

**FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy. 

© Copyright 2018-2026 One Health Company, All rights reserved

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "FidoCure",
    "url" : "https://blog.fidocure.com/fidocure-blog/author/fidocure"
  },
  "dateModified" : "2024-10-10T13:00:04.673Z",
  "datePublished" : "2024-10-10T13:00:00.000Z",
  "headline" : "Pancreatic Cancer in Dogs",
  "image" : [ "https://blog.fidocure.com/hubfs/Blog_PancreaticCancer.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.fidocure.com/fidocure-blog/pancreatic-cancer-in-dogs",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.fidocure.com/hubfs/fidocure_logo.png"
    },
    "name" : "FidoCure"
  }
}
```